DCA Waiver DCA-20-45, Order Waiving Restrictions on Pharmacies, Pharmacists and Pharmacy Technicians Relating to Ordering, Collecting Specimens for, and Performing COVID-19 Tests

The record

Jurisdiction

California Department of Consumer Affairs, Director (California State Board of Pharmacy); State level · California

Level

Sector regulator

Authority

Executive Orders N-39-20 and N-75-20; Cal. Gov't Code § 8571

Issued

2020-08-25 Aug. 25, 2020

Effective

2020-08-25 (effective immediately) (read as 2020-08-25)

End

May be amended from time to time in the discretion of the Director; no fixed termination stated (read as 2021-09-30)

In force

Aug. 25, 2020 to Sept. 30, 2021

Quarters

2020 Q32020 Q42021 Q12021 Q22021 Q3

2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3

Limitation types

Health care ordersOther

Addressees

• California pharmacies
• pharmacists
• pharmacy technicians under pharmacist supervision

Functions reached

• DX diagnostics (pharmacy point-of-care COVID-19 testing)
• SC pharmacy operations
• HR scope of practice (technicians)
• CB patients

Collection

State health licensing boards AGY-ST-HEALTH-BOARDS

Operative words

The Director waives Business and Professions Code section 1206.5, subdivision (a), section 1209, subdivision (a)(2), and section 1265, subdivision (b) to the extent they prohibit a pharmacy, pharmacist or pharmacy technician from performing on [site COVID-19 tests]... this Order remain[s] subject to the direct supervision and control of a supervising pharmacist, pursuant to Business and Professions Code section 4115, subdivision (a).... This Order is effective immediately, and may be amended from time to time in the discretion of the Director.

Enforcement

Notes